Seventh Sense gets $16M to develop painless blood-collection device

08/13/2014 | Xconomy · American City Business Journals

Cambridge, Mass.-based startup Seventh Sense Biosystems has received $16 million in new financing from a Series B funding round. The round included new investors Novartis, Laboratory Corp. and Siemens Financial's venture capital unit, as well as previous investors Flagship Ventures and Polaris Partners. Seventh Sense Biosystems is developing a touch-activated phlebotomy system that pierces only the outer layers of the skin for blood collection that is intended to be pain-free.

View Full Article in:

Xconomy · American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park